Ibd, Crohns Disease, Ulcerative Colitis, Precision Medicine, Research And Development.
healthcare expenses.⁵ It is therefore extremely important to identify factors that predict whether a patient will end up in this high-risk group. Not only does IBD progression vary from person to person, the on-again-off-again nature of this disease means that one person can experience the disease